BACKGROUND
Prostate cancer (PC) is the most common cancer in men in Germany, accounting for 29% of all malignancies. Since it cannot be prevented, improved diagnostics and therapy are required. Within the framework of so-called value-based healthcare, the Balanced Scorecard (BSC) has been established as a measurement i...
A. Panic, Peter Albers, Isabelle Bußhoff et al.· Urologie· 0 citations
BACKGROUND AND OBJECTIVE
Prostate-specific membrane-antigen positron emission tomography (PSMA-PET) detects distant metastases in more than half of patients with increasing prostate-specific antigen despite castrate levels of testosterone and high-risk nonmetastatic disease on conventional imaging. Here, we aim to eval...
C. Civan, M. Karpinski, C. Darr et al.· European Urology Focus· 0 citations
Chronicle is introduced, an explainable transformer that learns from entire patient trajectories, predicts diverse clinical outcomes throughout the disease course while capturing both short- and long-term temporal dependencies, providing a scalable framework to support individualized treatment decisions.
P. Keyl, N. Kiermeyer, J. Bosserhoff et al.· medRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.